Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanotechnology‐based approaches for treating lysosomal storage disorders, a focus on Fabry disease
Authors
Keywords
-
Journal
Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-12-14
DOI
10.1002/wnan.1684
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular vesicles increase the enzymatic activity of lysosomal proteins and improve the efficacy of enzyme replacement therapy in Fabry disease
- (2020) Ibane Abasolo et al. MOLECULAR GENETICS AND METABOLISM
- Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins
- (2020) Priyank Singhvi et al. TRENDS IN BIOTECHNOLOGY
- Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in mice
- (2020) Julie C. Ullman et al. Science Translational Medicine
- Analysis of Renal and Cardiac Outcomes in Male Participants in the Fabry Outcome Survey Starting Agalsidase Alfa Enzyme Replacement Therapy Before and After 18 Years of Age
- (2020) Rossella Parini et al. Drug Design Development and Therapy
- A Brief Reminder of Systems of Production and Chromatography-Based Recovery of Recombinant Protein Biopharmaceuticals
- (2019) B. Owczarek et al. Biomed Research International
- Exosome-mediated delivery of active glucocerebrosidase to Gaucher model cells
- (2019) Hojun Choi et al. MOLECULAR GENETICS AND METABOLISM
- Targeted nanoliposomes for the treatment of Fabry disease
- (2019) Ibane Abasolo et al. MOLECULAR GENETICS AND METABOLISM
- FACTs Fabry gene therapy clinical trial: Two-year data
- (2019) Jeffrey A. Medin et al. MOLECULAR GENETICS AND METABOLISM
- Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: a 1-year Phase 1/2 clinical trial
- (2019) Raphael Schiffmann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Pharmacokinetics, pharmacodynamics, and safety of moss-aGalactosidase A in patients with Fabry disease
- (2019) Julia B. Hennermann et al. JOURNAL OF INHERITED METABOLIC DISEASE
- The glycosylation design space for recombinant lysosomal replacement enzymes produced in CHO cells
- (2019) Weihua Tian et al. Nature Communications
- TPP1 Delivery to Lysosomes with Extracellular Vesicles and their Enhanced Brain Distribution in the Animal Model of Batten Disease
- (2019) Matthew J. Haney et al. Advanced Healthcare Materials
- Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies
- (2019) Mireia Pesarrodona et al. Advanced Science
- Targeted delivery of lysosomal enzymes to the endocytic compartment in human cells using engineered extracellular vesicles
- (2019) Mai Anh Do et al. Scientific Reports
- Release of targeted protein nanoparticles from functional bacterial amyloids: A death star-like approach
- (2018) Ugutz Unzueta et al. JOURNAL OF CONTROLLED RELEASE
- A Blood-Brain-Barrier-Penetrating Anti-human Transferrin Receptor Antibody Fusion Protein for Neuronopathic Mucopolysaccharidosis II
- (2018) Hiroyuki Sonoda et al. MOLECULAR THERAPY
- The New York pilot newborn screening program for lysosomal storage diseases: Report of the First 65,000 Infants
- (2018) Melissa P. Wasserstein et al. GENETICS IN MEDICINE
- Effects of Enzyme Replacement Therapy and Antidrug Antibodies in Patients with Fabry Disease
- (2018) Malte Lenders et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Biopharmaceutical benchmarks 2018
- (2018) Gary Walsh NATURE BIOTECHNOLOGY
- Lysosomal storage diseases
- (2018) Frances M. Platt et al. Nature Reviews Disease Primers
- Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy
- (2017) Alberto B. Burlina et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Emptying the stores: lysosomal diseases and therapeutic strategies
- (2017) Frances M. Platt NATURE REVIEWS DRUG DISCOVERY
- Achieving the Promise of Therapeutic Extracellular Vesicles: The Devil is in Details of Therapeutic Loading
- (2017) Dhruvitkumar S. Sutaria et al. PHARMACEUTICAL RESEARCH
- Bacterial Inclusion Bodies: Discovering Their Better Half
- (2017) Ursula Rinas et al. TRENDS IN BIOCHEMICAL SCIENCES
- Highly Versatile Polyelectrolyte Complexes for Improving the Enzyme Replacement Therapy of Lysosomal Storage Disorders
- (2016) Marina I. Giannotti et al. ACS Applied Materials & Interfaces
- Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
- (2016) Derralynn A Hughes et al. JOURNAL OF MEDICAL GENETICS
- α-Galactosidase-A Loaded-Nanoliposomes with Enhanced Enzymatic Activity and Intracellular Penetration
- (2016) Ingrid Cabrera et al. Advanced Healthcare Materials
- Strategies for the production of difficult-to-express full-length eukaryotic proteins using microbial cell factories: production of human alpha-galactosidase A
- (2015) Ugutz Unzueta et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A novel bio-functional material based on mammalian cell aggresomes
- (2015) Escarlata Rodríguez-Carmona et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry mice
- (2015) Jin-Song Shen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Lysosomal Storage Disorder Screening Implementation: Findings from the First Six Months of Full Population Pilot Testing in Missouri
- (2015) Patrick V. Hopkins et al. JOURNAL OF PEDIATRICS
- Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease
- (2015) Tali Kizhner et al. MOLECULAR GENETICS AND METABOLISM
- Polymer Capsules as a Theranostic Tool for a Universal In Vitro Screening Assay-The Case of Lysosomal Storage Diseases
- (2015) Moritz Nazarenus et al. PARTICLE & PARTICLE SYSTEMS CHARACTERIZATION
- Carboxyl-Terminal Truncations Alter the Activity of the Human α-Galactosidase A
- (2015) Mariam Meghdari et al. PLoS One
- The effectiveness and cost-effectiveness of enzyme and substrate replacement therapies: a longitudinal cohort study of people with lysosomal storage disorders.
- (2014) K Wyatt et al. HEALTH TECHNOLOGY ASSESSMENT
- Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)
- (2014) Martin L. Katz et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Enhancing Biodistribution of Therapeutic Enzymes In Vivo by Modulating Surface Coating and Concentration of ICAM-1-Targeted Nanocarriers
- (2013) Janet Hsu et al. Journal of Biomedical Nanotechnology
- Extracellular vesicles: Exosomes, microvesicles, and friends
- (2013) Graça Raposo et al. JOURNAL OF CELL BIOLOGY
- Multifunctional Nanovesicle-Bioactive Conjugates Prepared by a One-Step Scalable Method Using CO2-Expanded Solvents
- (2013) Ingrid Cabrera et al. NANO LETTERS
- Specific Transfection of Inflamed Brain by Macrophages: A New Therapeutic Strategy for Neurodegenerative Diseases
- (2013) Matthew J. Haney et al. PLoS One
- Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics
- (2012) José Luis Corchero et al. BIOTECHNOLOGY ADVANCES
- CNS Penetration of Intrathecal-Lumbar Idursulfase in the Monkey, Dog and Mouse: Implications for Neurological Outcomes of Lysosomal Storage Disorder
- (2012) Pericles Calias et al. PLoS One
- Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome
- (2012) Saskia M. Rombach et al. PLoS One
- Recent advances in stealth coating of nanoparticle drug delivery systems
- (2012) Zohreh Amoozgar et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- pH-Responsive Polysaccharide-Based Polyelectrolyte Complexes As Nanocarriers for Lysosomal Delivery of Therapeutic Proteins
- (2011) Marina I. Giannotti et al. BIOMACROMOLECULES
- Integrated approach to produce a recombinant, his-tagged human α-galactosidase a in mammalian cells
- (2011) José Luis Corchero et al. BIOTECHNOLOGY PROGRESS
- The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
- (2011) Suhrad G. Banugaria et al. GENETICS IN MEDICINE
- Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants
- (2011) Xu He et al. GLYCOBIOLOGY
- Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine
- (2011) Neus Ferrer-Miralles et al. Microbial Cell Factories
- Glycosylation of Therapeutic Proteins
- (2010) Ricardo J. Solá et al. BIODRUGS
- Enhanced endothelial delivery and biochemical effects of α-galactosidase by ICAM-1-targeted nanocarriers for Fabry disease
- (2010) Janet Hsu et al. JOURNAL OF CONTROLLED RELEASE
- Delivery of Therapeutic Proteins
- (2010) Dipak S. Pisal et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Fabry disease
- (2010) Dominique P Germain Orphanet Journal of Rare Diseases
- New biotechnological and nanomedicine strategies for treatment of lysosomal storage disorders
- (2010) Silvia Muro Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Glycan Engineering and Production of ‘Humanized’ Glycoprotein in Yeast Cells
- (2009) Yasunori Chiba et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Vasculopathy in patients with Fabry disease: Current controversies and research directions
- (2009) S.M. Rombach et al. MOLECULAR GENETICS AND METABOLISM
- Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells
- (2008) Jin-Song Shen et al. MOLECULAR GENETICS AND METABOLISM
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started